Back to Search
Start Over
Effect of Systemic Hydrocortisone Initiated 7 to 14 Days After Birth in Ventilated Preterm Infants on Mortality and Neurodevelopment at 2 Years' Corrected Age: Follow-up of a Randomized Clinical Trial.
- Source :
-
JAMA: Journal of the American Medical Association . 7/27/2021, Vol. 326 Issue 4, p355-357. 3p. - Publication Year :
- 2021
-
Abstract
- This follow-up to the STOP-BPD randomized clinical trial, which investigated the efficacy and safety of systemic hydrocortisone treatment initiated 7 to 14 days after birth in ventilator-dependent, very preterm infants in the Netherlands and Belgium at 36 weeks' postmenstrual age, examines the prespecified composite of death and neurodevelopmental impairment among these infants at 2 years' corrected age. [ABSTRACT FROM AUTHOR]
- Subjects :
- *HYDROCORTISONE
*DRUG efficacy
*NEURODEVELOPMENTAL treatment for infants
*DEVELOPMENT of premature infants
*INFANT mortality
*BRONCHOPULMONARY dysplasia
*CLINICAL trials
*BRONCHOPULMONARY dysplasia prevention
*PREMATURE infant diseases
*RESEARCH
*RESEARCH methodology
*MEDICAL cooperation
*EVALUATION research
*ARTIFICIAL respiration
*COMPARATIVE studies
*LONGITUDINAL method
MORTALITY risk factors
Subjects
Details
- Language :
- English
- ISSN :
- 00987484
- Volume :
- 326
- Issue :
- 4
- Database :
- Academic Search Index
- Journal :
- JAMA: Journal of the American Medical Association
- Publication Type :
- Academic Journal
- Accession number :
- 151664556
- Full Text :
- https://doi.org/10.1001/jama.2021.9380